Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D04KKE
|
|||
| Former ID |
DIB012227
|
|||
| Drug Name |
Diaziquone
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Solid tumour/cancer [ICD-11: 2A00-2F9Z; ICD-10: C76-C80; ICD-9: 140-229] | Discontinued in Phase 3 | [1] | |
| Company |
Medimmune Oncology Inc
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C16H20N4O6
|
|||
| Canonical SMILES |
CCOC(=O)NC1=C(C(=O)C(=C(C1=O)N2CC2)NC(=O)OCC)N3CC3
|
|||
| InChI |
1S/C16H20N4O6/c1-3-25-15(23)17-9-11(19-5-6-19)14(22)10(18-16(24)26-4-2)12(13(9)21)20-7-8-20/h3-8H2,1-2H3,(H,17,23)(H,18,24)
|
|||
| InChIKey |
WVYXNIXAMZOZFK-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 57998-68-2
|
|||
| PubChem Compound ID | ||||
| ChEBI ID |
CHEBI:90185
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800000771) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.